Avoid common mistakes on your manuscript.
Correction to: Current Psychiatry Reports (2023) 25:723–733.
The original version of this article unfortunately contained a mistake in the image of Fig. 1. Specifically, in section C. of this figure, the cut-off limit of prolactin is defined as 15 ng/L. The correct value of prolactin should be 25 ng/mL. The correct image is the following.
Evidence-based recommendations for female-specific pharmacotherapy, based on three pillars: sex-specific dosing, hormonal replacement, and correction of prolactin levels. Abbreviations: AP, antipsychotic; PANSS, Positive and Negative Syndrome Scale; TDM, therapeutic drug monitoring; COC, combined oral contraceptive; HC, hormonal contraceptive; ARI, aripiprazole. Footnotes: 1Based on Schoretsanitis et al. [77•]. 2Based on the Stages of Reproductive Aging Workshop (STRAW + 10). 3Should be based on shared decision, primarily led by preference and/or current use of the participant. 4Amisulpride, asenapine, chlorpromazine, haloperidol, lurasidone, olanzapine, paliperidone, and risperidone
The original version of this paper has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s11920-023-01460-6.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Brand, B.A., Willemse, E.J.M., Hamers, I.M.H. et al. Correction to: Evidence‑Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders. Curr Psychiatry Rep (2024). https://doi.org/10.1007/s11920-024-01520-5
Published:
DOI: https://doi.org/10.1007/s11920-024-01520-5